Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

Systemic lupus erythematosus, or lupus, is a complex autoimmune disease in which the immune system mistakenly attacks healthy tissue, often affecting the skin, joints, kidneys and nervous system.

Today, the Lupus Foundation of America announced a new, groundbreaking collaborative lupus clinical trial program – LFA Lupus ...

Learning the facts about lupus can mean the difference between early treatment and serious complications that impact quality ...

Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity ...

The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

HRT may be safe for people with lupus in certain instances. One 2022 review involving 16 studies found that HRT can help manage menopausal symptoms without the extra risk in most cases. Most studies ...

– Gazyva is the only anti-CD20 monoclonal antibody in a randomized Phase III study to demonstrate a complete renal response benefit – – The filing application is based on data from the Phase ...

People with lupus are more likely to develop asthma than those without the autoimmune condition. However, the exact association between both conditions is still unclear. Lupus is a chronic ...

Lupus-related antibody shows promise in enhancing cancer treatment efficacy Date: March 25, 2025 Source: Yale University Summary: Scientists have discovered a promising way to trigger immune ...

NEW YORK, March 20, 2025 /PRNewswire/ -- The Lupus Research Alliance (LRA) is proud to announce the inaugural recipients of the new Targeted Research Program on Engineered Cell Therapies for Lupus ...